Medifast
MED
301 hedge funds and large institutions have $2.82B invested in Medifast in 2021 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 107 increasing their positions, 92 reducing their positions, and 35 closing their positions.
74% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 35
37% more capital invested
Capital invested by funds: $2.06B → $2.82B (+$761M)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
16% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 92
9% more funds holding
Funds holding: 277 → 301 (+24)
2.15% more ownership
Funds ownership: 82.69% → 84.84% (+2.2%)
53% less call options, than puts
Call options by funds: $15.7M | Put options by funds: $33.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$19M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$15.3M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$12.8M |
| 4 |
EIP
Epoch Investment Partners
New York
|
+$10.9M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$21.6M |
| 2 |
Millennium Management
New York
|
-$13.8M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$9.59M |
| 4 |
BlackRock
New York
|
-$9.47M |
| 5 |
Goldman Sachs
New York
|
-$6.71M |
MED Hedge Fund Activity: Q2 2021 in Review
301 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q2 2021, worth a combined $2.82B — up 37% from $2.06B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new MED positions and 35 closed out — a net gain of 26 holders — while 107 added to existing stakes and 92 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $19M. The largest seller was Rice Hall James & Associates, cutting an estimated $21.6M.
- 301 institutional investors held Medifast (MED) as of Q2 2021, up from 277 in Q1 2021.
- Funds reported $2.82B of Medifast stock for Q2 2021, up 37% quarter-over-quarter.
- 61 funds opened new Medifast positions in Q2 2021 and 35 closed out, a net change of +26 holders.
- The largest Medifast buyer in Q2 2021 was Fidelity Investments, an estimated $19M added.
- The largest Medifast seller in Q2 2021 was Rice Hall James & Associates, an estimated $21.6M sold.
Based on aggregated 13F filings for Q2 2021.